help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHELLENBERG, D.
Right arrow Articles by SANDFORD, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHELLENBERG, D.
Right arrow Articles by SANDFORD, A. J.

Am. J. Respir. Crit. Care Med., Volume 157, Number 3, March 1998, 957-961

Vitamin D Binding Protein Variants and the Risk of COPD

DEVIN SCHELLENBERG, PETER D. PARÉ, TRACEY D. WEIR, JOHN J. SPINELLI, BLAIR A. M. WALKER, and ANDREW J. SANDFORD

Respiratory Health Network of Centres of Excellence, University of British Columbia Pulmonary Research Laboratory, St. Paul's Hospital, Vancouver, British Columbia

Although the development of chronic obstructive pulmonary disease (COPD) in smokers shows genetic susceptibility, only alpha 1-antitrypsin deficiency has been identified as a definite genetic risk factor. There have been three previous studies in which associations between Gc-globulin phenotypes and COPD have been investigated. Although some data suggest an association, the results were inconclusive. Because smoking is the major risk factor for COPD, it may have been a confounding factor in previous studies. We have investigated Gc-globulin genotypic frequencies among 75 COPD patients and 64 nonobstructed controls. Both groups had significant smoking histories: pack-years (mean ± SD) of 52 ± 30 and 48 ± 27, respectively. The results show that homozygosity for the Gc2 allele is protective against COPD (OR = 0.17, 95% CI = 0.03 to 0.83). There were no differences between genotypes for lung elastic recoil values or for the level of upstream airway resistance. Gc-globulin can enhance complement (C5a)-mediated neutrophil chemotaxis. Because neutrophils play a role in parenchymal destruction and airway inflammation, we examined whether Gc-globulin's ability to enhance neutrophil chemotaxis varied with genotype. We found no difference among genotypes with respect to neutrophil chemotaxis suggesting that the protective effect of the Gc2 allele is mediated through a different mechanism.




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
C. P. Hersh, D. L. DeMeo, and E. K. Silverman
National Emphysema Treatment Trial State of the Art: Genetics of Emphysema
Proceedings of the ATS, May 1, 2008; 5(4): 486 - 493.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W. C. Tan and T. P. Ng
COPD in Asia: Where East Meets West
Chest, February 1, 2008; 133(2): 517 - 527.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. Viegi, F. Pistelli, D. L. Sherrill, S. Maio, S. Baldacci, and L. Carrozzi
Definition, epidemiology and natural history of COPD
Eur. Respir. J., November 1, 2007; 30(5): 993 - 1013.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. J. Wright
Make No Bones About It: Increasing Epidemiologic Evidence Links Vitamin D to Pulmonary Function and COPD
Chest, December 1, 2005; 128(6): 3781 - 3783.
[Full Text] [PDF]


Home page
ChestHome page
N. A. Molfino
Genetics of COPD
Chest, May 1, 2004; 125(5): 1929 - 1940.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. R. Ouellette
The Answer Is Fifteen Percent: What Is the Question?
Chest, January 1, 2004; 125(1): 3 - 5.
[Full Text] [PDF]


Home page
ChestHome page
I. Ito, S. Nagai, Y. Hoshino, S. Muro, T. Hirai, M. Tsukino, and M. Mishima
Risk and Severity of COPD Is Associated With the Group-Specific Component of Serum Globulin 1F Allele
Chest, January 1, 2004; 125(1): 63 - 70.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
I Kasuga, P D Pare, J Ruan, J E Connett, N R Anthonisen, and A J Sandford
Lack of association of group specific component haplotypes with lung function in smokers
Thorax, September 1, 2003; 58(9): 790 - 793.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A J Sandford and E K Silverman
Chronic obstructive pulmonary disease * 1: Susceptibility factors for COPD the genotype-environment interaction
Thorax, August 1, 2002; 57(8): 736 - 741.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. K. Silverman
Genetic Epidemiology of COPD
Chest, March 1, 2002; 121(2007): 1S - 6S.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
T. Ishii, N. Keicho, S. Teramoto, A. Azuma, S. Kudoh, Y. Fukuchi, Y. Ouchi, and T. Matsuse
Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis
Eur. Respir. J., November 1, 2001; 18(5): 753 - 757.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L.-I. Ho, H.-J. Harn, C.-J. Chen, and N.-M. Tsai
Polymorphism of the {beta}2-Adrenoceptor in COPD in Chinese Subjects
Chest, November 1, 2001; 120(5): 1493 - 1499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. J. SANDFORD, T. CHAGANI, T. D. WEIR, J. E. CONNETT, N. R. ANTHONISEN, and P. D. PARÉ
Susceptibility Genes for Rapid Decline of Lung Function in the Lung Health Study
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 469 - 473.
[Abstract] [Full Text]


Home page
ThoraxHome page
P. J Barnes
Genetics and pulmonary medicine bullet  9: Molecular genetics of chronic obstructive pulmonary disease
Thorax, March 1, 1999; 54(3): 245 - 252.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society
  Solid Organ Transplant for the Intensivist 2008